RUNX2, RUNX family transcription factor 2, 860

N. diseases: 405; N. variants: 37
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0699790
Disease: Colon Carcinoma
Colon Carcinoma
0.090 Biomarker disease BEFREE The colon cancer HT-29 cell line and the normal CCD-18 CO colon cell line were used in the present study. 31646796 2020
CUI: C0699790
Disease: Colon Carcinoma
Colon Carcinoma
0.090 Biomarker disease BEFREE These results indicate that PVT1 could promote metastasis and proliferation of colon cancer via suppressing miR-30d-5p/RUNX2 axis, which may offer a new way for interpreting the mechanism of colon cancer development. 29552759 2019
CUI: C0699790
Disease: Colon Carcinoma
Colon Carcinoma
0.090 Biomarker disease BEFREE This study aims to elucidate the effects of ethanol extracts of LT (ELT) relative to the role of Runt-related transcription factor- (Runx-) 2 in the invasive and metastatic potentials of mouse colon cancer to determine the underlying mechanisms involved. 30105080 2018
CUI: C0699790
Disease: Colon Carcinoma
Colon Carcinoma
0.090 AlteredExpression disease BEFREE The normal colon epithelia cell line of CCD-18Co and six colon cancer cell lines with different expression levels of Beclin-1 were used in this study. 29738069 2018
CUI: C0699790
Disease: Colon Carcinoma
Colon Carcinoma
0.090 Biomarker disease BEFREE The antibacterial activity and the cytotoxic effects of the SNPs on the human lung carcinoma (A549), mouse colon carcinoma (CT26), Caco-2, and human fibroblast (CCD-986sk) cells were tested. 30184776 2018
CUI: C0699790
Disease: Colon Carcinoma
Colon Carcinoma
0.090 Biomarker disease BEFREE The TPM images of CCD-18co (a normal colon cell line) and HCT116 cells (a colon cancer cell line) labeled with BH-2 were too dim to be distinguished. 28806509 2017
CUI: C0699790
Disease: Colon Carcinoma
Colon Carcinoma
0.090 Biomarker disease BEFREE This study aimed to evaluate the cell growth inhibition activity of açai (Euterpe oleracea Mart.) polyphenolic extract against colon cancer HT-29 and SW-480 cells and the nonmalignant CCD-18Co colon fibroblast cells. 25329001 2014
CUI: C0699790
Disease: Colon Carcinoma
Colon Carcinoma
0.090 Biomarker disease BEFREE HT-29 and SW-480 colon cancer and normal CCD-18Co colon fibroblast cells were treated with curcuminoids previously analyzed by HPLC. 23471840 2013
CUI: C0699790
Disease: Colon Carcinoma
Colon Carcinoma
0.090 Biomarker disease BEFREE In addition, RUNX2 LI was significantly associated with adverse clinical outcome of the colon carcinoma patients, and turned out an independent prognostic factor following multivariate analysis. 22396198 2012